bioAffinity Technologies to Highlight CyPath Lung at North Carolina Event
bioAffinity Technologies will highlight its CyPath Lung test at a Nov. 5 healthcare event in North Carolina.
Related stories
X2M Connect Reports Q1 FY27 Revenue of A$1.4 Million
X2M Connect posted revenue of A$1.4 million for Q1 FY27.
M impact | EQUITY | Oct 30, 2026, 01:20 AM UTC
OncoSil Medical Q1 FY27 Sales Revenue Rises 45.8% Year On Year
M impact | EQUITY | Oct 30, 2026, 01:20 AM UTC
Xreality Group Posts Quarterly Annual Recurring Revenue of A$8.8 Million
M impact | EQUITY | Oct 30, 2026, 01:20 AM UTC
Hiremii Posts Q1 FY27 Revenue of A$7.056 Million
M impact | EQUITY | Oct 30, 2026, 01:19 AM UTC
Reece Reports Q1 FY27 Sales Revenue of A$2,510 Million
M impact | EQUITY | Oct 30, 2026, 01:19 AM UTC
Reece Reports Q1 FY27 Sales Revenue of A$2.510 Billion
M impact | EQUITY | Oct 30, 2026, 01:19 AM UTC